CN
149-57-5
应用筛选条件
关键词:'149-57-5'
显示 1-30 共 50 条结果 关于 "149-57-5" 范围 技术文档
Product Information Sheet - M2628
This product is soluble in 1 M NAOH
(5 mg/ml), yielding a dark, purple solution.
References
1. Farrar, W. V., Synthetic dyes before 1860.
Endeavour, 33, 149-154 (1974).
2. Travis, A. S., Artificial
Monoclonal Anti-Cytochrome P450 4F11 Clone F21P6F5 (C4868)
and Kaminsky, L.S., Annu. Rev.
Pharmacol. Toxicol., 43, 149-173 (2003).
4. Windmill, K.F., et al., Mutat. Res., 376, 153-160
(1997).
5. Simpson, A.E., Gen. Pharmacol., 28, 351-359
(1997).
6
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
2
129
131
132
133
134
135
149
78
134
140
145 152
144
141
139
142
129
135
133 126
Quality Control Range Sheet- HST-110 and HST-210
Control 1 17 – 34 pg/mL TNFα Control 1 15 – 30 pg/mL
Control 2 80 – 166 pg/mL Control 2 72 – 149 pg/mL
Monoclonal Anti-Cytochrome P450 3A5 Clone F18 P3 B6 (C4743)
, and Kaminsky, L.S., Annu. Rev.
Pharmacol. Toxicol., 43, 149-173 (2003).
4. Windmill, K.F., et al. Mutat. Res., 376, 153-160
(1997).
5. Daly, A.K., Clin. Pharmacokinet., 45, 13-31 (2006).
EK
Monoclonal Anti-Cytochrome P450 3A7 Clone F19P2H2 (C4993)
and Kaminsky, L.S., Annu. Rev.
Pharmacol. Toxicol., 43, 149-173 (2003).
4. Windmill, K.F., et al., Mutat. Res., 376, 153-160
(1997).
5. Rodriguez-Antona, C., et al., J. Biol. Chem., 280,
28324
Data Sheet - E5031
61, 547-556 (2004).
4. Michalak, M., J. App. Biomed., 3, 159-165 (2005).
5. Ritz, U., and Seliger, B., Mol. Med., 7, 149-158
(2001).
EK,KAA,PHC 08/06-1
Sigma brand products are sold through Sigma-Aldrich
Monoclonal Anti-Cytochrome P450 1A2 Clone 3B8C1 (C5118)
Pharmacol. Toxicol., 43, 149-173 (2003).
3. Windmill, K.F., et al., Mutat. Res., 376, 153-160
(1997).
4. Sheweita, S.A., Curr. Drug Metab., 1, 107-132
(2000).
5. Costas, I., et al., Curr
Product Information Sheet - 107689
, F.W. et al., Quart. Bull. Northw. Univ. Med.
Sch., 30, 138 (1956).
5. Lalezari, P., and Spaet, T.H., J. Lab. Clin. Med., 57,
868 (1971).
6. Grann, V.A. et al., Am. J. Clin. Pathol., 58, 26
Monoclonal Anti-Cytochrome P450 2C6 (CYP2C6) Clone K1 (C0746)
and Kaminsky, L.S., Annu. Rev.
Pharmacol. Toxicol., 43, 149-173 (2003).
4. Windmill, K.F., et al., Mutat. Res., 376, 153-160
(1997).
5. Goldstein, J.A., Br. J. Clin. Pharmacol., 52, 349-355
(2001
Product Information Sheet - P1411
10, 491 (1954).
4. Cornu, J., Ann. Microbiol., 131B, 121 (1980). (In French).
5. Lerner, H.R. et al., Physiol. Plant, 57, 90 (1983).
6. Schupp, J.M. et al., Biotechniques, 19, 18 (1995).
7. Molvig
Monoclonal Anti-B23 antibody produced in mouse (B0556)
Feuerstein, N., et al., J. Biol. Chem., 263, 10608-
10612 (1988).
5. Chan, P.K., and Chan, F.Y., Biochem.
Pharmacol., 57, 1265-1273 (1999).
6. Okuda, M., et al., Cell, 103, 127-140 (2000).
7
Product Information Sheet - H9268
, F.W. et al., Quart. Bull. Northw. Univ. Med.
Sch., 30, 138 (1956).
5. Lalezari, P., and Spaet, T.H., J. Lab. Clin. Med., 57,
868 (1971).
6. Grann, V.A. et al., Am. J. Clin. Pathol., 58, 26
Data Sheet - R1402
A., et al., Cardiovascular effects of
Raloxifene hydrochloride., Cardiovasc. Drug Rev.,
19, 57-74 (2001).
5. Kubatka, P., et al., Preventive effects of Raloxifene
and melatonin in N–methyl–N–nitrosourea–induced
QC Range Sheet MCKP1-110K
IFNγ Control 1 19 - 39 pg/mL BCA-1/CXCL-13 Control1 171 - 354 pg/ml
Control 2 72 - 149 pg/mL Control 2 747 - 1551 pg/ml
XP725 Antibody Number-Lot Number 071M4826
e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
IPI00387025 Ig kappa chain V-I region DEE 82 1 46 1
IPI00385252 Ig kappa chain V-III region GOL 149 2
IPI00385264 Ig mu heavy chain disease protein 48 1
IPI00061977 IGHA1 protein 212 3 211 4 170
Product Information Sheet - MPAA3
1 4 3 BSA
144 3 1 4 4 Positive
145 3 2 1 1 ILK
146 3 2 1 2 ILK
147 3 2 1 3 ILK
148 3 2 1 4 ILK
149 3 2 2 1 SAPK3
Aldrich Polymer Products Application - Ionx
4.8 0-14
43,668-2 88 - Mp 16-40 Na 45 150 1.8 1.8 0-14
43,661-5 650C - G 25-30 H 50 150 1.9 1.9 0-14
43,395-0 Marathon C - G 30-40 H 53 149 1.8 2.6 0-14
42,878-7 MSC-1 - - 20-50 Na 47 150
PKH Dye Reference Guide
Cancer Res. 1997; 57:
5033-5036.
24. Fox, D. Optimizing fluorescent labeling
of endothelial cells for tracking during long
term studies of autologous transplantation.
5-21-1997. Chicago
Data Sheet - 74188
Kornfeld, S. Kornfeld, Ann. Rev. Biochem., 1985, 54, 631.
27 W.M. Watkins, Carbohydr. Res., 1986, 149, 1.
28 A.T. Beyer, et al., Adv. Enzymol., 1981, 52, 24.
29 J.E. Sadler, et al., Method. Enzymol
Impurities & Related Compounds: Reference Materials
-26-5
540-84-1
20535-83-5
149-57-5
345-92-6
874-43-1
51-78-5
123-42-2
103931-20-0
60-31-1
1466-82-6
530-75-6
121268-17-5
23828-92-4
37517-28-5
39831-55-5
User Guide - Z756997
............................... 57
10.1 Enter sample designation...................................................................................................... 57
10.2 Set date/time for measuring
Product Information - CSAA1
G9038 Neurobiology P y y y
148 Glutamic Acid Decarboxylase (GAD65/67) G5163 Neurobiology P y y y
149 Glutamine Syntethase G2781 Neurobiology P n/d n/d y
150 Nerve growth factor receptor (NGFR p75) N3908
59505 Galactosyltransferase Kit
Kornfeld, S. Kornfeld, Ann. Rev. Biochem., 1985, 54, 631.
27 W.M. Watkins, Carbohydr. Res., 1986, 149, 1.
28 A.T. Beyer, et al., Adv. Enzymol., 1981, 52, 24.
29 J.E. Sadler, et al., Method.
Nutrition Research
.........5 mg/mL in ethanol
J R: 11 S: 7-16 Fp: 14 °C (57 °F) NB WET ICE
A8105-1MG 1 mg
A8105-5MG 5 mg
cis-4,7,10,13,16,19-Docosahexaenoic acid
DHA
C22H32O2 FW 328.49 [6217-54-5] BRN 1715505
KERN ABT
D-72336 Balingen
E-Mail: info@kern-sohn.com
Tel: +49-[0]7433- 9933-0
Fax: +49-[0]7433-9933-149
Internet: www.kern-sohn.com
Operating instruction
Analytical balance
KERN
ACS Manual
49-[0]7433/9933-149
8 ACJ/ACS-BA-e-1211
3 Appliance overview
1. Weighing plate
2.
Titrette Digital Bottle-Top Burette Manual
mostrate ripetutamente
una dopo l'altra le seguenti
modalità:
CAL - GLP - APO - dP.
149
3
5
1
2
Pulizia
Pulizia standard
1. Posizionare la valvola
Bioreactor Systems for Bone Tissue Engineering
bioreactor system with
a standard well plate and two parallel Helmholtz coils being
kept in a PMMA tube.149 The applied PEMF frequency used
in that study was 75 Hz with an intensity of 2 mT and the
magnetic
1/2